The agent assembled a partial answer about Oasys Therapeutics by fetching the homepage, about page, and products page, but could not find critical information about pricing, availability, or how to access the product. The site's minimal content and absence of key pages (pricing, ordering, contact, FAQ) made it impossible to fully answer the task despite reasonable exploratory effort.

• ›Step [1] (homepage) and step [2] (about page) provided the company's mission statement and target market (160M+ Americans with xerostomia), but only in meta descriptions and truncated HTML; the agent could not access full rendered body content due to the Astro JavaScript framework.
• ›Step [5] (products page) was the only substantive content source, confirming the product name SIPITOAS™ and its positioning as 'custom-molded blend of saliva stimulants,' but again only via meta description—full product details, clinical evidence, and specifications were not retrievable from the fetch response.
• ›Steps [3], [6], [7], [9], [10], [13], [14], [26], [27] all returned 404s (/pricing, /how-it-works, /science, /contact, /blog, /resources, /faq, /get-started, /order), revealing that the site has virtually no secondary pages; the site is essentially three static pages (home, about, products) with no e-commerce, documentation, or support infrastructure exposed.
• ›The agent's web searches [11], [15], [17], [18], [20], [21], [23], [24] yielded no results from the domain itself and failed to locate SIPITOAS in pharmacy databases, competitor comparisons, clinical trial registries, or press releases, suggesting the product may not yet be market-available or FDA-approved.
• ›The agent had to resort to prior knowledge (83% of fetches sourced from prior knowledge per run metadata) because the site's HTML responses were truncated and did not render interactive content; the agent could not determine pricing, ordering process, clinical status, or target channel (consumer vs. clinical) from any page it reached.